|

BCMA/CD70 CAR-T cells Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Chongqing Precision Biotech Co., Ltd1

Indications

  • Systemic Lupus Erythematosus1
  • Lupus1

Other1 trial

Study of Ultra-Fast BCMA/CD70 CAR-T Therapy for Refractory SLE
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.